Quantum Biopharma Ltd. (QNTM)

NASDAQ · Pharmaceuticals & Biotech · Pharmaceutical Preparations

Price
$3.88
Day
+4.86%

Close 2026-09-23.

The company

A. History and Development of the Company Corporate History Effective November 1, 1998, pursuant to the amalgamation of Olympic ROM World Inc., 1305206 Ontario Company, 1305207 Ontario Inc., Century Financial Capital Group Inc. and Dunberry Graphic Associates Ltd. in accordance with the provisions of the OBCA, the Company was formed. Effective May 24, 2018, following receipt of shareholder approval at the March 15, 2018 annual and special meeting of the proposed amendments to the Company’s articles, and pursuant to the articles of amendment, the Company changed its name to “FSD Pharma Inc.” and the capital structure of the Company was reorganized to create a new class of Class A multiple voting shares (the “ Class A Multiple Voting Shares ”), amended the terms of and re-designated the existing common shares as Class B subordinate voting shares (the “ Class B Subordinate Voting Shares ”), and eliminate the existing non-voting class A preferred shares and non-voting class B preferred shares. Effective May 29, 2018, the Class B Subordinate Voting Shares commenced trading on the CSE under the trading symbol “HUGE”. Effective October 16, 2019, the Company completed a 201:1 consolidation.

From Item 1: A. History and Development of the Company · Corporate History.

Institutional holders

Largest positions reported on Form 13F for the quarter ended 2026-06-30, by value.

Recent filings